|
Match
|
Document |
Document Title |
|
|
7589083 |
Compounds and compositions to control abnormal cell growth
A class of compounds commonly containing a trialkylammonium group have been synthesized and characterized as anticancer compounds. A representative of this class,...
|
|
|
7576094 |
Spiro derivatives as lipoxygenase inhibitors
The present invention is concerned with certain novel spiro substituted heterocylic ring derivatives. These compounds may be useful in the manufacture of pharmaceutical compositions for treating...
|
|
|
7482344 |
Tricyclic steroid hormone nuclear receptor modulators
The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula I in...
|
|
|
7423029 |
Compounds to promote regeneration of bone marrow
Embodiments of the present invention include the use of heterocyclic trialkyl ammonium-containing compounds to promote regeneration of bone marrow from endogenous or exogenous stem/progenitor cells...
|
|
|
7288560 |
Spirocyclic cyclohexane derivatives
The present invention relates to spirocyclic cyclohexane compounds, to methods for their production, to pharmaceutical compositions containing these compounds, to methods of treatment using such...
|
|
|
7268148 |
Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
Acne-affected skin has been found to be accompanied by the presence of matrix-degrading enzymes such as MMPs and neutrophil elastase, induction of neutrophils, and a reduction in procollagen...
|
|
|
7238725 |
Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
The present invention relates to novel tricyclic compounds useful for the treatment of inflammatory conditions, diseases of the central nervous and insulin resistant diabetes.
|
|
|
7223774 |
Benzamide 2-hydroxy-3-diaminoalkanes
The present invention relates to compounds of formula (I):
useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme...
|
|
|
7115605 |
Peptide deformylase inhibitors
PDF inhibitors and novel methods for their use are provided.
|
|
|
7105569 |
Fungicidal active compound combinations
New active compound combinations of valinamide derivatives of the formula (I)
in which
R 1 and R 2 has the meaning given in the description,
with known fungicidal active substances,...
|
|
|
7019024 |
Pharmaceutical for treatment of neurological and neuropsychiatric disorders
The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula:
or a pharmaceutically acceptable salt thereof.
|
|
|
6825226 |
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
The invention relates to the discovery that specific adamantyl or adamantyl group derivatives containing retinoid-related compounds induce apoptosis of cancer cells and therefore may be used for...
|
|
|
6806283 |
Selective serotonin receptor antagonists and therapeutic applications thereof
Spiro[9,10-dihydroanthracene]-9,3′-pyrrolidine (SPAN) and derivatives thereof are provided as selective serotonin receptor antagonists. The compounds are selective, high affinity antagonists of...
|
|
|
6784202 |
Cubane derivatives as metabotropic glutamate receptor agonists or antagonists and process for their preparation
The present invention relates to therapeutically active cubane compounds, a method of preparing the same, and to pharmaceutical compositions comprising the compounds. The novel compounds are useful...
|
|
|
6767919 |
High specificity anticancer agents
A process for producing new anticancer drugs such that the drugs can be administered in a nontoxic, proto-drug form and, subsequent to a time delay which allows for differential concentration in...
|
|
|
6730697 |
Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid
Dihydrothiaphenanthrenecarbonylguanidine compound of formula I These compounds are potentially suitable as antiarrythmic medicaments with a cardioprotective component for prophylaxis of an...
|
|
|
6693136 |
Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptors
Compounds of formula (I) are novel P2X 3 and P2X 2 /P2X 3 containing receptor antagonists and are useful in treating pain, urinary incontinence, and bladder overactivity.
|
|
|
6620834 |
Medicinal compositions for treating colorectal cancer
Medicinal compositions for colorectal cancer to be administered to the large intestine by taking advantage of preparations disintegrating in the large intestine, characterized by containing a...
|
|
|
6613797 |
Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
Therapeutic compounds and compositions for the treatment of infectious diseases are disclosed. The compounds are xanthones and xanthone derivatives, such as...
|
|
|
6602903 |
Substituted heterocyclic compounds
The invention relates to compounds of formula (I): and medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
|
|
|
6566389 |
Therapeutic uses of melatonin
A method for treating or preventing symptoms of tardive dyskensia comprises administering melatonin to patient exhibiting or liable to develop such symptoms. The melatonin is administered in an...
|
|
|
6521641 |
Male anti-fertility agents
Methods and compositions for inhibiting or preventing spermatogenesis in a male mammal. Also disclosed are compounds and formulations for use in such methods.
|
|
|
6514967 |
Compound for preparing medicines for treating pathologies involving extracellular glutamate, and methods for obtaining same
The invention relates to compounds of the following general formula (I): in which: R 1 and R 2 represent a hydrogen atom, or form a ring, especially a benzene ring, R 3 represents a hydrogen...
|
|
|
6511968 |
Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
The invention provides a method for treating, preventing, or reducing the risk of developing a condition selected from the group consisting of acute coronary ischemic syndrome, thrombosis,...
|
|
|
6391911 |
Coadministration of lucanthone and radiation for treatment of cancer
Disclosed is a method of treating a cancer of the central nervous system in a host including administering radiation to the host; and administering lucanthone to the host; wherein the radiation and...
|
|
|
6384045 |
Tricyclic and tetracyclic pyrones
This invention provides cancer-active tricyclic and tetracyclic oxypyrones and a method of synthesizing these compounds. Preferred compounds have aryl groups at the 3-position of the oxypyrone...
|
|
|
6258836 |
Dopamine analog amide
The invention involves the formation of a prodrug from a fatty acid carrier and a neuroactive drug. The prodrug is stable in the environment of both the stomach and the bloodstream and may be...
|
|
|
6245797 |
Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
The instant invention provides a drug combination comprised of an HMG-CoA reductase inhibitor in combination with a COX-2 inhibitor, which is useful for treating, preventing, and/or reducing the...
|
|
|
6172058 |
Compounds with pharmaceutical properties
A pharmaceutical compound of the formula ##STR1## in which R 1 is C 1 -10 alkyl, C 2 -10 alkenyl, C 2 -10 alkynyl, C 3 -10 cycloalkyl, C 3 -10 cycloalkyl-C 1 -10 alkyl, C 3 -10 cycloalkyl-C 2 -10...
|
|
|
6117869 |
Compounds for and methods of inhibiting matrix metalloproteinases
The present invention relates to compounds of Formula I that inhibit matrix metalloproteinases and to a method of inhibiting matrix metalloproteinases using the compounds ##STR1## More...
|
|
|
6100253 |
Tricycle substituted with azaheterocyclic carboxylic acids
The present invention relates to novel N-substituted azaheterocyclic compounds of the general formula ##STR1## wherein X, Y, Z, R 1 , R 2 and r are as defined in the detailed part of the present...
|
|
|
6054448 |
2-amino-2-(3-substituted cyclobutyl) acetic acid derivatives
Compounds of the formula ##STR1## in which R 1 is Y or Y--C 1 -6 alkyl, where Y is carboxy, tetrazolyl, --SO 2 H, --SO 3 H, --OSO 3 H, --CONHOH, or --P(OH)OR', --PO(OH)OR', --OP(OH)OR' or...
|
|
|
5994392 |
Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
The invention involves the formation of a prodrug from a fatty acid carrier and a neuroactive drug. The prodrug is stable in the environment of both the stomach and the bloodstream and may be...
|
|
|
5990104 |
Polycyclic alcaloid-derivatives as NMDA-receptor antagonists
Polycyclic alkaloids of formula (I), wherein R 1 is H, C 1 -6 alkyl, or C 6 -12 aryl optionally substituted with polar groups; R 2 and R 3 are independently H, OH, C 1 -6 alkyl, --C(NH)--NH 2 ,...
|
|
|
5977077 |
Xanthone analogs for the treatment of infectious diseases
Therapeutic compositions for the treatment of infectious diseases are disclosed. These compositions comprise xanthones and xanthone derivatives, such as 2,3,4,5,6-pentahydroxyxanthone. Also...
|
|
|
5891899 |
Pharmaceutical xanthene compounds
A pharmaceutical compound of the formula: ##STR1## in which A is carboxy, tetrazolyl, --SO 2 H, --SO 3 H, --OSO 3 H, --CONHOH, or --P(OH)OR', --PO(OH)OR', --OPO(OH)OR' B is a bond, C 1 -6...
|
|
|
5880146 |
Inhibition of IL-12-induced IFN-γ synthesis by specific bis-phenol compounds as a method of immune modulation
Disclosed are chemical agents for modulating certain cellular immune reactions that can lead to autoimmune disorders. By specific modulation, harmful immune reactions can be lessened in severity or...
|
|
|
5827856 |
Method of treating insulin resistance
The present invention provides a novel method for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting...
|
|
|
5726208 |
Heterocyclic tertiary amines
New compounds of formula: ##STR1## wherein: --A--D--E, X, n, Y and Z are as defined in the description, in racemic form and in the form of optical isomers, and their addition salts with...
|
|
|
5665760 |
Lyophilized thioxanthenone antitumor agents
Disclosed are reconstituted lyophilized formulations for the treatment of mammalian tumors comprising a thioxanthenone antitumor agent in combination with mannitol or sucrose as a stabilizer in a...
|
|
|
5571825 |
Method of selectively inhibiting prostaglandin G/H synthase-2
The present invention provides a method of selectively inhibiting prostaglandin G/H synthase-2 that comprises administering to a patient in need of such inhibition an inhibiting amount of a...
|
|
|
5550110 |
Endothelin Antagonists II
Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute...
|
|
|
5447960 |
Fungicidal use of phenolic aromatic compounds
A plant fungicide method comprises applying to the locus of a plant pathogen a fungicidally effective amount of a compound of formula (I) ##STR1## or a salt or a complex thereof, wherein: R 1 , R 2...
|
|
|
5438056 |
Heterocyclic oxime carbamates
The compounds of the present invention have the following formula: ##STR1## wherein R 1 and R 2 are independently phenyl, pyridyl, thienyl, naphthyl, substituted phenyl wherein the substituent is...
|
|
|
5380749 |
Thioxanthenone antitumor agents
1-[[(Dialkylamino)alkyl]amino]-4-substituted-thioxanthen-9-o
nes are disclosed as antitumor agents. Compositions containing the thioxanthenones and methods of treating tumors and cancer in mammals...
|
|
|
5276053 |
Polycyclic amines useful as cerebrovascular agents
A novel series of polycyclic amines, derivatives, methods of making the compounds, novel intermediates, compositions containing them, and methods for using them in the treatment and prevention of...
|
|
|
5196445 |
Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases
Heteroaryl-3-oxo-propanenitrile derivatives of formula (I) ##STR1## wherein X represents an oxygen atom or a --CH(R 4 )--, --O--CH(R 4 )--, --S(O) n --CH(R 4 )--, --CH(R 4 )--O--, --CH(R 4 )--S(O)...
|
|
|
5192765 |
Certain amines which are muscarinic receptor antagonists
Amines of the following formula: ##STR1## where the variables are defined in the specification are useful in the treatment of diseases associated with altered motility and/or tone of smooth muscle.
|
|
|
5104858 |
Sensitizing multidrug resistant cells to antitumor agents
A method for sensitizing multidrug resistant cells to antitumor agents comprosing contacting multidrug resistant cells, with an effective amount of a compound of the formula ##STR1## wherein n is...
|
|
|
5071853 |
Polycyclic amines useful as cerebrovascular agents
A novel series of polycyclic amines, derivatives, methods of making the compounds, novel intermediates, compositions containing them, and methods for using them in the treatment and prevention of...
|